Validation of suicide and self-harm records in the clinical practice research datalink

British Journal of Clinical Pharmacology

Volumn 76, Issue 1, 2013, Pages 145-157

  Thomas, Kyla H ^a   Davies, Neil ^a   Metcalfe, Chris ^a   Windmeijer, Frank ^a   Martin, Richard M ^a   Gunnell, David ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Clinical Practice Research Datalink; General Practice Research Database; Nonfatal self harm; Suicide; Validation

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUTOMUTILATION; CLINICAL PRACTICE RESEARCH DATALINK; DATA BASE; DISEASE CLASSIFICATION; DISEASE REGISTRY; DRUG INDUCED DISEASE; ELECTRONIC MEDICAL RECORD; FEMALE; GENERAL PRACTITIONER; HOSPITAL ADMISSION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICAL RECORD REVIEW; MORTALITY; PREDICTIVE VALUE; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY AND SPECIFICITY; SEX RATIO; SUICIDE; VALIDITY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CLINICAL CODING; DATABASES, FACTUAL; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; GENERAL PRACTITIONERS; GREAT BRITAIN; HUMANS; INCIDENCE; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MIDDLE AGED; SELF-INJURIOUS BEHAVIOR; SEX DISTRIBUTION; SUICIDE; YOUNG ADULT;

EID: 84879483004     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12059     Document Type: Article

References (34)

1. Rodriguez LAG, Gutthann SP. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 1998; 45: 419-425.
2. Lawrenson R, Williams T, Farmer R. Clinical information for research; the use of general practice databases. J Public Health Med 1999; 21: 299-304.
3. Harpaz R, Dumouchel W, Shah NH, Madigan D, Ryan P, Friedman C. Novel data-mining methodologies for adverse drug event discovery and analysis. Clin Pharmacol Ther 2012; 91: 1010-1021.
4. Gunnell D, Saperia J, Ashby D. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. BMJ 2005; 330: 385-388.
5. Martinez C, Rietbrock S, Wise L, Ashby D, Chick J, Moseley J, Evans S, Gunnell D. Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study. BMJ 2005; 330: 389-393.
6. Rubino S, Roskell N, Tennis P, Mines D, Weich S, Andrews E. Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study. BMJ 2007; 334: 242.
7. Gunnell D, Irvine D, Wise L, Davies C, Martin RM. Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database. BMJ 2009; 339: b3805.
8. Arana A, Wentworth CE, Ayuso-Mateos JL, Arellano FM. Suicide-related events in patients treated with antiepileptic drugs. N Engl J Med 2010; 363: 542-551.
9. Black C, Jick H. Etiology and frequency of rhabdomyolysis. Pharmacotherapy 2002; 22: 1524-1526.
10. Schade R, Andersohn F, Suissa S, Haverkamp W, Garbe E. Dopamine agonists and the risk of cardiac-valve regurgitation. N Engl J Med 2007; 356: 29-38.
11. Department of Health. Investing in General Practice: The New General Medical Services Contreact. London: Department of Health, 2003.
12. Parkinson J, Davies S, Van Staa T. The General Practice Research database: now and future. In: Pharmacovigilance, 2nd edn, eds Mann R, Andrews E. Chichester: Wiley, 2007; 341-348.
13. Hawton K, Fagg J, Simkin S, Bale E, Bond A. Trends in deliberate self-harm in Oxford, 1985-1995. Implications for clinical services and the prevention of suicide. [see comments]. Br J Psychiatry 1997; 171: 556-560.
14. Gunnell D, Bennewith O, Peters TJ, Stocks N, Sharp DJ. Do patients who self-harm consult their general practitioner soon after hospital discharge? A cohort study. Soc Psychiatry Psychiatr Epidemiol 2002; 37: 599-602.
15. Cooper J, Murphy E, Jordan R, Mackway-Jones K. Communication between secondary and primary care following self-harm: are National Institute of Clinical Excellence (NICE) guidelines being met? Ann Gen Psychiatry 2008; 7: 21. doi:10.1186/1744-859X-7-21.
16. Coroners Statistics 2010 England and Wales. In: Justice Mo, editor: Crown copyright, 2011.
17. Hall GC. Validation of death and suicide recording on the THIN UK primary care database. Pharmacoepidemiol Drug Saf 2009; 18: 120-131.
18. Arana A, Wentworth CW, Arellano FM. Validity of the codes of suicidality in the THIN database. Pharmacoepidemiol Drug Saf 2010; 19: 1316-1317.
19. Jick SS, Kaye JA, Vasilakis-Scaramozza C, Rodriguez LAG, Ruigomez A, Meier CR, Schlienger RG, Black C, Jick H. Validity of the General Practice Research Database. Pharmacotherapy 2003; 23: 686-689.
20. Jick SS, Dean AD, Jick H. Antidepressants and suicide. BMJ 1995; 310: 215-218.
21. Garcia-Rodriguez LA, Perez-Gutthann S, Jick S. The UK General Practice Research Database. In: Pharmacoepidemiology, ed. Strom BL. Chichester: John Wiley & Sons Ltd, 2002; 375-385.
22. Office for National Statistics. Suicide rates in the United Kingdom 2000-2009. In: Statistical Bulletin, Newport: Crown Copyright, 2011: 1-10.
23. Hawton K, Bergen H, Casey D, Simkin S, Palmer B, Cooper J, Kapur N, Horrocks J, House A, Lilley R, Noble R, Owens D. Self-harm in England: a tale of three cities - multicentre study of self-harm. Soc Psychiatry Psychiatr Epidemiol 2007; 42: 513-521.
24. Bergen H, Hawton K, Waters K, Cooper J, Kapur N. Epidemiology and trends in non-fatal self-harm in three centres in England: 2000-2007. Br J Psychiatry 2010; 197: 493-498.
25. Brock A, Baker A, Griffiths C, Jackson G, Fegan G, Marshall D. Suicide trends and geographical variations in the United Kingdom, 1991-2004. Health Stat Q 2006; 31: 6-22.
26. Linsley KR, Schapira K, Kelly TP. Open verdict v. suicide - importance to research. Br J Psychiatry 2001; 178: 465-468.
27. Kapur N, House A, Creed F, Feldman E, Friedman T, Guthrie E. Management of deliberate self poisoning in adults in four teaching hospitals: descriptive study. BMJ 1998; 316: 831-832.
28. Bennewith O, Gunnell D, Peters TJ, Hawton K, House A. Variations in the hospital management of self-harm in adults in England: an observational study. BMJ 2004; 328: 1108-1109.
29. Doll R. Comparison between registries. Age-standardized rates. In: Cancer Incidence in Five Continents, Vol. III, eds Waterhouse J, Muir C, Correa P, Powell J. Lyon: International Agency for Research on Cancer, IARC Scientifc Publications No. 15, 1976: 453-459.
30. Hawton K, Zahl D, Weatherall R. Suicide following deliberate self-harm: long-term follow-up of patients who presented to a general hospital. Br J Psychiatry 2003; 182: 537-542.
31. Webb RT, Kontopantelis E, Doran T, Qin P, Creed F, Kapur N. Risk of self-harm in physically ill patients in UK primary care. J Psychosom Res 2012; 73: 92-97.
32. Hesdorffer DC, Ishihara L, Mynepalli L, Webb DJ, Weil J, Hauser WA. Epilepsy, suicidality, and psychiatric disorders: a bidirectional association. Ann Neurol 2012; 72: 184-191.
33. Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 2010; 69: 4-14.
34. Thomas KH, Beech E, Gunnell DJ. Changes in commonly used methods of suicide in England and Wales from 1901-1907 to 2001-2007. J Affect Disord 2013; 144: 235-239.